SILO PHARMA, INC. Crypto Asset Unrealized Gain Loss Nonoperating
SILO PHARMA, INC. (SILO) reported Crypto Asset Unrealized Gain Loss Nonoperating of -$35.80 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:CryptoAssetUnrealizedGainLossNonoperating · last filed 2026-08-13
- SILO PHARMA, INC. crypto asset unrealized gain loss nonoperating for the quarter ending 2026-06-30 was -$35.80K.
- SILO PHARMA, INC. crypto asset unrealized gain loss nonoperating for the quarter ending 2026-03-31 was -$53.35K.
- SILO PHARMA, INC. crypto asset unrealized gain loss nonoperating for the quarter ending 2025-12-31 was -$61.92K.
| Period end | Crypto Asset Unrealized Gain Loss Nonoperating 3 month | Crypto Asset Unrealized Gain Loss Nonoperating 6 month | Crypto Asset Unrealized Gain Loss Nonoperating 9 month | Crypto Asset Unrealized Gain Loss Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$35.80K 10-Q · filed 2026-08-13 | -$89.14K 10-Q · filed 2026-08-13 | -$151.06K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$53.35K 10-Q · filed 2026-05-14 | -$115.27K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2025-12-31 | -$61.92K derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | -$64.61K POS AM · filed 2026-04-14 | ||
| 2025-09-30 | -$2.69K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |